503 filings
Page 23 of 26
6-K
8efyje
18 Apr 19
Current report (foreign)
6:13am
6-K
l4wan
12 Apr 19
Current report (foreign)
6:09am
6-K
frx8e m4jt98x
8 Apr 19
Current report (foreign)
6:22am
6-K
kko wbiy36hpu7
3 Apr 19
Dr. Sarah Fakih joins MorphoSys as Head of Corporate
6:10am
6-K
wn7uqoj
21 Mar 19
MorphoSys andI-Mab Biopharma Announce Initiation of Pivotal
6:17am
6-K
qpksw
21 Mar 19
Current report (foreign)
6:14am
6-K
ise7m mdv
15 Mar 19
2018 annual report Morphosys Engineering the Medicines of Tomorrow
6:27am
6-K
dbbnk
15 Mar 19
MorphoSys Presents Results for Fiscal Year 2018
6:23am
6-K
yf6lcc97fagw25cy83e
11 Mar 19
MorphoSys Provides Updates onL-MIND andB-MIND Clinical Trials of MOR208 in Relapsed/Refractory DLBCL
7:33am
6-K
4f0n4 eabsdlnx2844
28 Feb 19
Current report (foreign)
8:59am
6-K
vv0e1 127bx9if3l
28 Feb 19
Current report (foreign)
6:22am
6-K
gau5rrdhg
19 Feb 19
Current report (foreign)
9:51am
6-K
klm1v87ix8p13tptc4j
7 Feb 19
MorphoSys Announces Appointment of David Trexler as President
6:18am
6-K
es3sg7zavjsrd c6o
30 Jan 19
Current report (foreign)
7:49am
6-K
5lvwh9wj4lmj0swx04
18 Jan 19
MorphoSys Announces that its Licensee Janssen has Expanded
12:00am
6-K
c1puc
18 Jan 19
Current report (foreign)
12:00am
6-K
ouabqu9 wchse98m2fm
17 Dec 18
Current report (foreign)
9:58am
6-K
ckifc5ppzg78w3 e7d
12 Dec 18
MorphoSys’s Licensee Janssen Announces Data from the Phase 3
9:30am
6-K
4epzbyv
7 Dec 18
Current report (foreign)
9:47am
6-K
6ycmk2sb3b 8na
6 Dec 18
MorphoSys Presents Updated Data fromL-MIND Study of MOR208 in combination with Lenalidomide in r/r DLBCL at ASH 2018
6:35am